Picture courtesy The Indian Express
New Delhi: The Drugs Controller General of India (DCGI) has granted emergency use authorization to the COVID-19 vaccine Covovax for 12-17 years age group, PTI reported on Wednesday quoting official sources.
Covovax, the Indian version of US-developed Novavax, is manufactured in this country by Serun Institute of India.
It is the fourth COVID vaccine to receive regulator’s nod for use among under-18 age group.
The other three are Bharat Biotech’s Covaxin, which is being used to vaccinate those aged between 15 and 18 years after getting clearance last December; Zydus Cadila’s ZyCov-D which became the first one to be cleared by DCGI for those above 12 in August 2021; Biological E’s Corbevax for 12-18 years approved last month.
DCGI gave the nod to Covovax for emergency use authorization among adults on December 28, 2021, but it’s yet to be included in India’s vaccination drive.
Bhubaneswar: Prime Minister Narendra Modi concluded his mega roadshow in Bhubaneswar with an assertion that…
New Delhi: The Rouse Avenue Court on Friday ordered framing of sexual harassment charges against…
Bhubaneswar: In a retaliation to BJD leader VK Pandian's challenge to Union Minister Dharmendra Pradhan,…
Bhubaneswar: Odisha players Debasis Sahoo and Sohini Sanjay Mohanty had to be content with runner-up…
Bhubaneswar: Making people aware is the key to fighting Lupus, a little-known disease which mostly…
Bhubaneswar: Prime Minister Narendra Modi started his roadshow for simultaneous elections in Odisha from the…
New Delhi: Out of jail after being lodged in Tihar for 50 days, Arvind Kejriwal…
Puri: The construction work of the chariots for Rath Yara began with cutting of wood…